AI assistant
Sending…
CNA FINANCIAL CORP — Director's Dealing 2012
May 21, 2012
30494_dirs_2012-05-21_fa74272e-1831-4e5c-bc28-28fd831b7116.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CNA FINANCIAL CORP (CNA)
CIK: 0000021175
Period of Report: 2012-05-17
Reporting Person: Wilson Peter W (President & COO, CNA Specialty)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-05-17 | Common Stock | M | 5000 | $24.69 | Acquired | 5000 | Direct |
| 2012-05-17 | Common Stock | S | 5000 | $28.56 | Disposed | 0 | Direct |
| 2012-05-17 | Common Stock | A | 15000 | $28.80 | Acquired | 9005 | Direct |
| 2012-05-17 | Common Stock | F | 4146 | $28.80 | Disposed | 4859 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-05-17 | Stock Option | $24.69 | M | 5000 | Disposed | 2013-05-07 | Common Stock (5000) | Direct |
| 2012-05-17 | Stock Appreciation Rights | $11.51 | M | 15000 | Disposed | 2019-02-04 | Common Stock (15000) | Direct |
Footnotes
F1: The option became exercisable in four equal annual installments beginning on May 7, 2004.
F2: The Reporting Person received the Derivative Security pursuant to a stock option at no cost.
F3: The option became exercisable in four equal annual installments beginning on February 4, 2009.
F4: The Reporting Person received the Stock Appreciation Rights at no cost.
F5: The Reporting Person exercised 15,000 Stock Appreciation Rights and as such received a gain of 9,005 shares of the issuers common stock.
More from CNA FINANCIAL CORP
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 4
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 29
Regulatory Filings
2026
Mar 27
Director's Dealing
2026
Mar 20
Annual Report
2026
Mar 20
Proxy Solicitation & Information Statement
2026
Mar 20
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17